WS #10425

15:18→15:42 UTC
From 498 msgs · 10 key-dev

AbbVie acquires Apogee Therapeutics for $10.9B in cash, a significant biotech M&A deal with pipeline focus on atopic dermatitis and asthma.

Biotech M&A: AbbVie Acquires Apogee

AbbVie acquires Apogee Therapeutics for $10.9B in cash, a significant biotech M&A deal with pipeline focus on atopic dermatitis and asthma.

Full world state #10425 →

US-Iran Oil De-escalationAI Memory Demand SurgeUK Political Transition
← WS #10424WS #10426 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|